Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017871
Filing Date
2019-11-19
Accepted
2019-11-18 18:14:30
Documents
82
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 827632
2 ex10-3.htm EX-10.3 343219
3 ex31-1.htm EX-31.1 11931
4 ex31-2.htm EX-31.2 11699
5 ex32-1.htm EX-32.1 10616
  Complete submission text file 0001493152-19-017871.txt   6379602

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mbii-20190930.xml EX-101.INS 996855
7 XBRL SCHEMA FILE mbii-20190930.xsd EX-101.SCH 92559
8 XBRL CALCULATION FILE mbii-20190930_cal.xml EX-101.CAL 91552
9 XBRL DEFINITION FILE mbii-20190930_def.xml EX-101.DEF 326262
10 XBRL LABEL FILE mbii-20190930_lab.xml EX-101.LAB 597008
11 XBRL PRESENTATION FILE mbii-20190930_pre.xml EX-101.PRE 438394
Mailing Address 1540 DREW AVENUE DAVIS CA 95618
Business Address 1540 DREW AVENUE DAVIS CA 95618 530-750-2800
MARRONE BIO INNOVATIONS INC (Filer) CIK: 0001441693 (see all company filings)

EIN.: 205137161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36030 | Film No.: 191228598
SIC: 2870 Agricultural Chemicals